Expert Session: Reduce Raw Material Testing Burden—Without Compromising Compliance

Watch this free expert session to learn how pharmaceutical manufacturers implement skip-lot testing to reduce incoming raw material testing while maintaining quality, compliance, and patient safety.

In this session, you'll learn

  • Key regulatory and technical requirements for implementing your skip-lot testing program
  • How QA teams assess supplier performance and manage risk
  • Practical approaches to supplier qualification and ongoing monitoring
  • Real-world examples of skip-lot testing programs

Access the recording while it remains available.

Presented by experienced pharmaceutical technical experts.

Content aligned with ICH Q7 and FDA 21 CFR guidance.

Who Should Watch?

  • Quality Assurance (QA) professionals
  • Quality Control (QC) teams
  • Regulatory Affairs professionals
  • Technical Services teams
  • Procurement and Supplier Quality professionals

Why Watch?

  • Explore opportunities to reduce analytical testing workload
  • Understand regulatory expectations for skip-lot testing
  • Learn practical risk-based approaches used by manufacturers
  • Gain insights that can support operational efficiency and supply continuity